Avenue Biosciences, a protein engineering technology company based in Helsinki, has recently announced a Seed extension of €4.8 million ($5.7 million) to further develop their high-throughput...
Laigo Bio, a pioneering company based in Utrecht, is leading the way in developing innovative therapies using its unique SureTAC precision membrane protein degradation platform. Recently,...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.